In the last four years, six new drugs have been approved by the United States Food and Drug Administration for the treatment of kidney cancer. They … [Read more...]
SHARP Trial (Sorafenib Hepatocellular Carcinoma Assessment Randomized Protocol)
The SHARP trial investigated the efficacy (usefulness) of the oral multikinase inhibitor sorafenib (Nexavar) in the treatment of hepatocellular … [Read more...]